A 50-year-old morbidly obese woman presents to a primary care clinic for the first time. She states that her father recently died due to kidney failure and wants to make sure she is healthy. She works as an accountant, is not married or sexually active, and drinks alcohol occasionally. She currently does not take any medications. She does not know if she snores at night but frequently feels fatigued. She denies any headaches but reports occasional visual difficulties driving at night. She further denies any blood in her urine or increased urinary frequency. She does not engage in any fitness program. She has her period every 2 months with heavy flows. Her initial vital signs reveal that her blood pressure is 180/100 mmHg and heart rate is 70/min. Her body weight is 150 kg (330 lb). On physical exam, the patient has droopy eyelids, a thick neck with a large tongue, no murmurs or clicks on cardiac auscultation, clear lungs, a soft nontender, albeit large abdomen, and palpable pulses in her distal extremities. She can walk without difficulty. A repeat measurement of her blood pressure shows 155/105 mmHg. Which among the following is part of the most appropriate next step in management?

Renal artery doppler ultrasonography

Activation of the renin-angiotensin-aldosterone system yields a significant physiological effect on renal blood flow and filtration. Which of the following is most likely to occur in response to increased levels of Angiotensin-II?

Decreased renal plasma flow, increased filtration fraction

Decreased renal plasma flow, decreased filtration fraction

Decreased renal plasma flow, increased glomerular capillary oncotic pressure

Increased renal plasma flow, decreased filtration fraction

Increased renal plasma flow, increased filtration fraction

A 72-year-old woman with a medical history significant for chronic kidney disease stage 4, hypertension, and type 2 diabetes mellitus, presents to the office for a scheduled visit. During her last visit, the physician started discussing with her the possibility of starting her on dialysis for her chronic kidney disease. The patient has no complaints about her health and enjoys spending time with her family. At presentation, she is afebrile; the blood pressure is 139/89 mm Hg and the heart rate is 80/min. On physical examination, her pulses are bounding, the complexion is pale, she has a grade ⅙ holosystolic murmur, breath sounds remain clear, and 2+ pedal edema to the knee. The measurement of which of the following laboratory values is most appropriate to screen for renal osteodystrophy in this patient?

Serum intact parathyroid hormone level

Serum thyroid-stimulating hormone level

CKD etiology and pathophysiology for USMLE Step 3: High-Yield Internal Medicine Lessons

CKD Definition & Staging - Know The Score

Definition: Kidney damage (e.g., albuminuria) OR Glomerular Filtration Rate (GFR) <60 mL/min/1.73m² for >3 months.
Staging (KDIGO 2012): Classified by cause, GFR category (G-stage), and albuminuria category (A-stage).

GFR Stage	GFR (mL/min/1.73m²)	Description
G1	≥90	Normal or high
G2	60-89	Mildly decreased
G3a	45-59	Mildly-moderately ↓
G3b	30-44	Moderately-severely ↓
G4	15-29	Severely decreased
G5	<15	Kidney Failure

Albuminuria Stage	ACR (mg/g)	Description
A1	<30	Normal to mildly ↑
A2	30-300	Moderately ↑
A3	>300	Severely ↑

CKD Etiology - The Usual Suspects

Diabetes Mellitus (#1 Cause):
- Hyperglycemia → non-enzymatic glycation of proteins → GBM thickening.
- Leads to diabetic nephropathy.
- Pathognomonic finding: Kimmelstiel-Wilson lesions (nodular glomerulosclerosis).
Hypertension (#2 Cause):
- Chronic high pressure damages renal vessels → nephrosclerosis.
- Causes hyaline arteriolosclerosis of small arterioles.
- Leads to glomerulosclerosis and interstitial fibrosis.

Diabetic nephropathy vs. amyloidosis histology

⭐ In diabetic nephropathy, the earliest detectable change is microalbuminuria. Regular screening is crucial for early intervention.

CKD Pathophysiology - The Vicious Cycle

Hyperfiltration Hypothesis: The final common pathway in CKD. Initial nephron loss from any cause (e.g., diabetes, HTN) forces remaining nephrons to increase their single-nephron GFR to compensate.
The Cycle:
- This sustained hyperfiltration ↑ glomerular capillary pressure and shear stress.
- Causes endothelial and podocyte injury, leading to glomerulosclerosis.
- Results in proteinuria and progressive interstitial fibrosis.
- Ultimately, this destroys more nephrons, perpetuating the cycle.

CKD Pathophysiology: Hemodynamic and Tubular Hypotheses

Key Mediators:
- Angiotensin II: Drives efferent arteriole vasoconstriction (↑ pressure) and stimulates TGF-β.
- TGF-β: Key cytokine promoting fibrosis.
- Proteinuria: Directly toxic to tubular cells, causing inflammation and scarring.

⭐ ACE inhibitors and ARBs slow CKD progression by blocking Angiotensin II, thus dilating the efferent arteriole, which decreases intraglomerular pressure and reduces proteinuria.

Systemic Complications - Uremia's Domino Effect

Complication	Pathophysiology & Key Features
Anemia	Normocytic anemia from ↓ erythropoietin (EPO) production. Iron deficiency may coexist.
CKD-Mineral Bone Disorder (MBD)	↓ active Vit D & ↑PO₄ retention → ↓serum $Ca^{2+}$ → ↑PTH (secondary hyperparathyroidism) & ↑FGF-23. Leads to renal osteodystrophy.
Metabolic Acidosis	Impaired excretion of H⁺ and reabsorption of $HCO_3^−$, leading to a high anion gap metabolic acidosis.
Uremic Syndrome	Accumulation of waste products. Manifests as encephalopathy (asterixis), uremic pericarditis, and platelet dysfunction (bleeding).

High‑Yield Points - ⚡ Biggest Takeaways

Diabetes and hypertension are the leading causes of CKD.

Pathophysiology involves nephron loss, leading to compensatory hyperfiltration and eventual glomerulosclerosis.

Persistent albuminuria is a key marker of kidney damage and predicts progression.

Uremic symptoms manifest late, typically when GFR is <15 mL/min.

Major complications include anemia (↓ EPO), mineral and bone disorder (secondary hyperparathyroidism), and metabolic acidosis.

ACE inhibitors/ARBs are crucial for slowing progression, especially with proteinuria.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play